Page last updated: 2024-10-24

carmustine and Deficiency of Glucose-6-Phosphate Dehydrogenase

carmustine has been researched along with Deficiency of Glucose-6-Phosphate Dehydrogenase in 3 studies

Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sagone, AL1
Burton, GM1
Hohl, RJ1
Kennedy, EJ1
Frischer, H2
Ahmad, T1

Other Studies

3 other studies available for carmustine and Deficiency of Glucose-6-Phosphate Dehydrogenase

ArticleYear
The effect of BCNU and adriamycin on normal and G6PD deficient erythrocytes.
    American journal of hematology, 1979, Volume: 7, Issue:2

    Topics: Carmustine; Doxorubicin; Erythrocytes; Formates; Glucosephosphate Dehydrogenase Deficiency; Glutathi

1979
Defenses against oxidation in human erythrocytes: role of glutathione reductase in the activation of glucose decarboxylation by hemolytic drugs.
    The Journal of laboratory and clinical medicine, 1991, Volume: 117, Issue:4

    Topics: Carbon Dioxide; Carmustine; Decarboxylation; Erythrocytes; Glucose; Glucosephosphate Dehydrogenase D

1991
Consequences of erythrocytic glutathione reductase deficiency.
    The Journal of laboratory and clinical medicine, 1987, Volume: 109, Issue:5

    Topics: Carmustine; Diamide; Dinitrochlorobenzene; Erythrocytes; Glucosephosphate Dehydrogenase Deficiency;

1987